Pseudomonas

3 registered clinical trials studyying Pseudomonas.

Status	Trial	Sponsor	Phase
Unknown	Impact of Modifications to the Rendering of the Antibiogram on the Prescriptions of Meropenem in Pseudomonas B NCT06113107	University Hospital, Strasbourg, France	—
Completed	Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aerugi NCT04596319	Armata Pharmaceuticals, Inc.	Phase 1 / Phase 2
Completed	Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis NCT02894684	Liverpool Heart and Chest Hospital NHS Foundation Trust	Phase 4